05:08 PM EDT, 07/14/2025 (MT Newswires) -- Simulations Plus ( SLP ) said late Monday it invested $1 million in clinical technology firm Nurocor as part of its effort to support early-stage tech companies and identify potential partners.

The investment is expected to help Nurocor further speed up the clinical trial lifecycle and reduce development costs for clients to bring drugs to market more rapidly, Simulations Plus ( SLP ) said.